Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,015,846
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
15,752,840
-
Shares change
-
-475,564
-
Total reported value, excl. options
-
$135,465,315
-
Value change
-
-$5,391,551
-
Put/Call ratio
-
4.05%
-
Number of buys
-
30
-
Number of sells
-
-33
-
Price
-
$8.6
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2021
84 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q2 2021.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,752,840 shares
of 96,015,846 outstanding shares and own 16.41% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3,041,645 shares), 5AM Venture Management, LLC (2,984,263 shares), Cormorant Asset Management, LP (1,611,623 shares), BOXER CAPITAL, LLC (1,603,361 shares), MILLENNIUM MANAGEMENT LLC (990,330 shares), Ikarian Capital, LLC (947,128 shares), VANGUARD GROUP INC (730,199 shares), Redmile Group, LLC (696,378 shares), BAKER BROS. ADVISORS LP (636,363 shares), and WELLINGTON MANAGEMENT GROUP LLP (534,700 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.